Werewolf Therapeutics, Inc. Competitors
Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|---|
ACET
|
Adicet Bio, Inc. | $1.31 | $110.93 M | -0.46 | 143 | $0 |
ACRV
|
Acrivon Therapeutics, Inc. Common Stock | $7.80 | $223.86 M | -2.51 | 58 | $0 |
ANEB
|
Anebulo Pharmaceuticals, Inc. | $1.88 | $56.28 M | -5.86 | 2 | $0 |
CCCC
|
C4 Therapeutics, Inc. | $6.10 | $320.64 M | -1.97 | 145 | $20.76 M |
CELC
|
Celcuity Inc. | $15.25 | $501.59 M | -5.14 | 55 | $0 |
CGEM
|
Cullinan Oncology, Inc. | $15.98 | $1.29 B | -7.16 | 85 | $0 |
CSBR
|
Champions Oncology, Inc. | $4.27 | $62.53 M | -6.39 | 210 | $50.16 M |
CYT
|
Cyteir Therapeutics, Inc. | $3.02 | $108.71 M | -3.25 | 46 | $0 |
DBTX
|
Decibel Therapeutics, Inc. | $4.91 | $123.37 M | -1.93 | 68 | $0 |
DSGN
|
Design Therapeutics, Inc. | $5.55 | $217.51 M | -3.7 | 57 | $0 |
ELYM
|
Eliem Therapeutics, Inc. | $5.11 | $258.33 M | -17.08 | 9 | $0 |
EWTX
|
Edgewise Therapeutics, Inc. | $35.91 | $1.65 B | -11.47 | 97 | $0 |
GLUE
|
Monte Rosa Therapeutics, Inc. | $9.36 | $243.38 M | -1.59 | 129 | $0 |
IKNA
|
Ikena Oncology, Inc. | $1.71 | $84.45 M | -1.11 | 18 | $9.16 M |
MNOV
|
MediciNova, Inc. | $1.63 | $67.19 M | -8.06 | 13 | $1.00 M |
MOLN
|
Molecular Partners AG | $5.75 | $135.05 M | -2.03 | 167 | $7.04 M |
PASG
|
Passage Bio, Inc. | $0.64 | $73.04 M | -0.77 | 58 | $0 |
STOK
|
Stoke Therapeutics, Inc. | $13.07 | $774.50 M | -6.14 | 110 | $8.78 M |
TALS
|
Talaris Therapeutics, Inc. | $2.72 | $116.44 M | -1.56 | 84 | $0 |
THRD
|
Third Harmonic Bio, Inc. | $12.42 | $581.89 M | -18.95 | 42 | $0 |
VOR
|
Vor Biopharma Inc. | $0.78 | $83.62 M | -0.69 | 168 | $0 |